Clinical Research Directory
Browse clinical research sites, groups, and studies.
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
Sponsor: Elana Rosenthal
Summary
This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improving health outcomes in people hospitalized with an infection related to injecting opioids or stimulants.
Official title: Continuum of Care in Hospitalized Patients With Opioid or Stimulant Use Disorder and Infectious Complications of Drug Use - Substance Use/ID Integrated Clinic vs. TAU to Prevent Infection Related Readmission
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
304
Start Date
2024-10-01
Completion Date
2027-07-30
Last Updated
2025-10-31
Healthy Volunteers
No
Interventions
Integrated Infectious Diseases and Substance Use Disorder Clinic (IC)
Integrated medication for opioid/stimulant use disorder and infectious disease care provided into single appointment either in person or via telemedicine with a minimum of monthly appointments for 6 months.
Locations (4)
George Washington University
Washington D.C., District of Columbia, United States
Emory University
Atlanta, Georgia, United States
University of Maryland Baltimore
Baltimore, Maryland, United States
West Virginia University
Morgantown, West Virginia, United States